NO993997L - Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol - Google Patents

Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol

Info

Publication number
NO993997L
NO993997L NO993997A NO993997A NO993997L NO 993997 L NO993997 L NO 993997L NO 993997 A NO993997 A NO 993997A NO 993997 A NO993997 A NO 993997A NO 993997 L NO993997 L NO 993997L
Authority
NO
Norway
Prior art keywords
triene
diol
secokolesta
calcidol
alpha
Prior art date
Application number
NO993997A
Other languages
Norwegian (no)
Other versions
NO993997D0 (en
Inventor
Paul Trouillas
Original Assignee
Paul Trouillas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Trouillas filed Critical Paul Trouillas
Publication of NO993997D0 publication Critical patent/NO993997D0/en
Publication of NO993997L publication Critical patent/NO993997L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention concerns the use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol, for preparing a medicine for the treatment and/or prevention of solid cancer in human beings, in particular lung cancer and brain cancer. The effective dose ranges between 0.25 and 10 mu g/day for an adult weighing 60 Kg.
NO993997A 1997-02-20 1999-08-19 Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol NO993997L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702247A FR2759586B1 (en) 1997-02-20 1997-02-20 ANTI-CANCER TYPE DRUG COMPRISING AT LEAST AS THE ACTIVE INGREDIENT OF 1-ALPHA HYDROXYCALCIFEROL OR ALFACALCIDOL
PCT/FR1998/000347 WO1998036754A1 (en) 1997-02-20 1998-02-20 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol

Publications (2)

Publication Number Publication Date
NO993997D0 NO993997D0 (en) 1999-08-19
NO993997L true NO993997L (en) 1999-10-19

Family

ID=9504159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993997A NO993997L (en) 1997-02-20 1999-08-19 Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol

Country Status (15)

Country Link
EP (1) EP0981350B1 (en)
JP (1) JP2001511818A (en)
KR (1) KR20000075514A (en)
CN (1) CN1248168A (en)
AT (1) ATE206306T1 (en)
AU (1) AU6505098A (en)
BR (1) BR9807592A (en)
CA (1) CA2282086A1 (en)
DE (1) DE69801907D1 (en)
FR (1) FR2759586B1 (en)
IL (1) IL131502A0 (en)
NO (1) NO993997L (en)
PL (1) PL335190A1 (en)
TR (1) TR199901998T2 (en)
WO (1) WO1998036754A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004026811A (en) * 2002-04-30 2004-01-29 Kiyoshi Hashizume Medicament for reinforcing anti-cancer activity, containing vitamin d3 derivative
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
IL110117A0 (en) * 1994-06-24 1994-10-07 Univ Ben Gurion Pharmaceutical compositions comprising vitamin-d analogs

Also Published As

Publication number Publication date
DE69801907D1 (en) 2001-11-08
ATE206306T1 (en) 2001-10-15
CN1248168A (en) 2000-03-22
TR199901998T2 (en) 1999-11-22
AU6505098A (en) 1998-09-09
NO993997D0 (en) 1999-08-19
CA2282086A1 (en) 1998-08-27
EP0981350A1 (en) 2000-03-01
FR2759586B1 (en) 2000-01-14
BR9807592A (en) 2000-02-22
PL335190A1 (en) 2000-04-10
JP2001511818A (en) 2001-08-14
WO1998036754A1 (en) 1998-08-27
IL131502A0 (en) 2001-01-28
EP0981350B1 (en) 2001-10-04
FR2759586A1 (en) 1998-08-21
KR20000075514A (en) 2000-12-15

Similar Documents

Publication Publication Date Title
CS553490A3 (en) Transdermal therapeutic system
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
AP9801392A0 (en) Concentrated antibody preparation.
HK1032759A1 (en) Apparatus for restoring the balance of the human body.
IL131010A (en) Aryl sulfonamides and analogues thereof, processes for their preparation and pharmaceutical compositions comprising them in the treatment of neurodegenerative diseases
EP0671920A4 (en) An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease.
UA43378C2 (en) Composition for treating the respiratory distress- syndrome of the newborns and respiratory distress- syndrome of the adult
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
EP0744176A3 (en) Methods for inhibiting bone loss
EP0592903A3 (en) Use of ancrod for the preparation of drugs for the treatment of restenosis.
NL300083I1 (en) 1-Beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide for the preparation of a medicament for the medical treatment of humans.
DK0719276T3 (en) Estradiol esters with strong oral action as well as pharmaceutical preparations containing them
NO993997D0 (en) Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol
AU2379997A (en) Remedy for external application, and use of an oil-in-water emulsion for said remedy
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
SE8704471L (en) SOLARIUM
MY114109A (en) The use of bioassimilable boron compounds
AU6819898A (en) Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ATE74767T1 (en) MEDICINAL COMPOSITION FOR THE TREATMENT OF LUNG OCCLUSION.
IT8467837A0 (en) 4,4'-(2-PYRIDINIL METHYLENE)BISPENOL DIACETATE AND PHARMACEUTICAL PRODUCTS INCLUDING IT FOR THE TREATMENT OF HERPES SIMPLEX
KR970005296A (en) Tonsillitis Treatment
BG98003U (en) Medicament for the treatment of dermatomycosis
IT8422685A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR THE TREATMENT OF PSYCHOMOTOR EXCEPTION.